Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Asterias Biotherapeutics Inc stock logo
AST
Asterias Biotherapeutics
$0.00
$0.00
$0.51
$2.05
$111KN/A136,653 shs1,000 shs
Zendesk, Inc. stock logo
ZEN
Zendesk
$77.48
$76.91
$54.16
$130.83
$9.63B0.892.76 million shs3.64 million shs
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Asterias Biotherapeutics Inc stock logo
AST
Asterias Biotherapeutics
0.00%0.00%0.00%0.00%0.00%
Zendesk, Inc. stock logo
ZEN
Zendesk
0.00%0.00%0.00%0.00%0.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Asterias Biotherapeutics Inc stock logo
AST
Asterias Biotherapeutics
$0.00
$0.00
$0.51
$2.05
$111KN/A136,653 shs1,000 shs
Zendesk, Inc. stock logo
ZEN
Zendesk
$77.48
$76.91
$54.16
$130.83
$9.63B0.892.76 million shs3.64 million shs
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Asterias Biotherapeutics Inc stock logo
AST
Asterias Biotherapeutics
0.00%0.00%0.00%0.00%0.00%
Zendesk, Inc. stock logo
ZEN
Zendesk
0.00%0.00%0.00%0.00%0.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Asterias Biotherapeutics Inc stock logo
AST
Asterias Biotherapeutics
0.00
N/AN/AN/A
Zendesk, Inc. stock logo
ZEN
Zendesk
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Asterias Biotherapeutics Inc stock logo
AST
Asterias Biotherapeutics
N/AN/AN/AN/AN/AN/A
Zendesk, Inc. stock logo
ZEN
Zendesk
$1.34B7.19$0.14 per share550.43$2.79 per share27.77
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Asterias Biotherapeutics Inc stock logo
AST
Asterias Biotherapeutics
N/AN/A0.00N/AN/AN/AN/AN/A
Zendesk, Inc. stock logo
ZEN
Zendesk
-$223.64M-$2.31N/AN/AN/A-17.82%-48.53%-7.34%N/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Asterias Biotherapeutics Inc stock logo
AST
Asterias Biotherapeutics
N/AN/AN/AN/AN/A
Zendesk, Inc. stock logo
ZEN
Zendesk
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Asterias Biotherapeutics Inc stock logo
AST
Asterias Biotherapeutics
N/AN/AN/A
Zendesk, Inc. stock logo
ZEN
Zendesk
3.28
1.83
1.83

Institutional Ownership

CompanyInstitutional Ownership
Asterias Biotherapeutics Inc stock logo
AST
Asterias Biotherapeutics
N/A
Zendesk, Inc. stock logo
ZEN
Zendesk
90.15%

Insider Ownership

CompanyInsider Ownership
Asterias Biotherapeutics Inc stock logo
AST
Asterias Biotherapeutics
N/A
Zendesk, Inc. stock logo
ZEN
Zendesk
2.92%
CompanyEmployeesShares OutstandingFree FloatOptionable
Asterias Biotherapeutics Inc stock logo
AST
Asterias Biotherapeutics
N/A55.66 millionN/ANot Optionable
Zendesk, Inc. stock logo
ZEN
Zendesk
5,860124.24 million120.61 millionOptionable

Recent News About These Companies

Ready or not, enterprises are betting on AI
Hackers claim Discord breach exposed data of 5.5 million users
Asterias Biotherapeutics stock logo

Asterias Biotherapeutics NYSEAMERICAN:AST

$0.0020 0.00 (0.00%)
As of 07/10/2019

Asterias Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing cell-based therapeutics to treat neurological conditions associated with demyelination, and cellular immunotherapies to treat cancer. Its clinical stage programs include AST-OPC1, an oligodendrocyte progenitor cell population derived from pluripotent stem cells that is in Phase I/IIa clinical trial for spinal cord injuries; AST-VAC2 is a non-patient-specific cancer immunotherapy derived from pluripotent stem cells for the treatment of non-small cell lung cancer; and AST-VAC1, a patient-specific cancer immunotherapy that has completed Phase II clinical trial for the treatment of acute myeloid leukemia. The company was formerly known as BioTime Acquisition Corporation and changed its name to Asterias Biotherapeutics, Inc. in March 2013. Asterias Biotherapeutics, Inc. was founded in 2012 and is headquartered in Fremont, California.

Zendesk stock logo

Zendesk NYSE:ZEN

Zendesk, Inc., a software development company, provides software as a service solutions for organizations in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. Its flagship product is Zendesk Support, a system for tracking, prioritizing, and solving customer support tickets across various channels. The company also offers Zendesk Chat, a live chat and messaging software to connect with customers on websites and mobile devices applications; Zendesk Talk, a cloud-based call center software; Zendesk Guide, a knowledge base that powers customer self-service and support agent productivity; Zendesk Gather, a community forum software that allows customer end-users to connect and collaborate; Zendesk Explore, which provides analytics for organizations to measure and enhance the customer experience; and Zendesk Sell, a sales customer relationship management (CRM) product solution to enhance productivity, processes, and pipeline visibility. In addition, it provides Zendesk Sunshine, a CRM platform; Sunshine Conversations, a messaging platform solution; Zendesk Developer Tools, a combination of application programming interfaces, web widget, and mobile software development kits; Zendesk APIs that allow users to build custom integrations and interact with Zendesk data; and Zendesk Apps that enable organizations to customize Zendesk product and platform solution interfaces and optimize workflow through plug-ins, as well as Zendesk Suite, an omnichannel offering, which combines its solutions. The company was founded in 2007 and is headquartered in San Francisco, California.